JP2015037545A5 - - Google Patents

Download PDF

Info

Publication number
JP2015037545A5
JP2015037545A5 JP2014156280A JP2014156280A JP2015037545A5 JP 2015037545 A5 JP2015037545 A5 JP 2015037545A5 JP 2014156280 A JP2014156280 A JP 2014156280A JP 2014156280 A JP2014156280 A JP 2014156280A JP 2015037545 A5 JP2015037545 A5 JP 2015037545A5
Authority
JP
Japan
Prior art keywords
seq
sequence
protein
composition
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014156280A
Other languages
English (en)
Japanese (ja)
Other versions
JP5750703B2 (ja
JP2015037545A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2015037545A publication Critical patent/JP2015037545A/ja
Publication of JP2015037545A5 publication Critical patent/JP2015037545A5/ja
Application granted granted Critical
Publication of JP5750703B2 publication Critical patent/JP5750703B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014156280A 2008-09-24 2014-07-31 細胞接着を予防するペプチド及び組成物、並びにこれを使用する方法 Active JP5750703B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13667308P 2008-09-24 2008-09-24
US61/136,673 2008-09-24

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2011527422A Division JP5676451B2 (ja) 2008-09-24 2009-09-23 ペプチド

Publications (3)

Publication Number Publication Date
JP2015037545A JP2015037545A (ja) 2015-02-26
JP2015037545A5 true JP2015037545A5 (https=) 2015-04-09
JP5750703B2 JP5750703B2 (ja) 2015-07-22

Family

ID=41698391

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011527422A Active JP5676451B2 (ja) 2008-09-24 2009-09-23 ペプチド
JP2014156280A Active JP5750703B2 (ja) 2008-09-24 2014-07-31 細胞接着を予防するペプチド及び組成物、並びにこれを使用する方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2011527422A Active JP5676451B2 (ja) 2008-09-24 2009-09-23 ペプチド

Country Status (12)

Country Link
US (3) US9029318B2 (https=)
EP (3) EP2789626B1 (https=)
JP (2) JP5676451B2 (https=)
KR (2) KR101594202B1 (https=)
CN (2) CN104892728A (https=)
AU (1) AU2009295575B2 (https=)
CA (1) CA2737682C (https=)
ES (2) ES2690348T3 (https=)
HK (1) HK1213903A1 (https=)
IL (1) IL211930A (https=)
SG (2) SG10201504623VA (https=)
WO (1) WO2010035107A2 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101801521B (zh) 2007-05-14 2015-06-17 纽约州立大学研究基金会 生物膜中细菌细胞内的生理学分散响应诱导
KR101594202B1 (ko) * 2008-09-24 2016-02-15 텔 하쇼머 메디컬 리서치 인프라스트럭쳐 앤드 서비시스 리미티드. 세포 유착 방지를 위한 펩티드와 조성물 및 그것의 사용 방법
EP2376528B1 (en) * 2008-12-29 2014-11-26 Tel Hashomer Medical Research, Infrastructure And Services Ltd. Peptides and compositions for prevention of cell adhesion and methods of using same
US11174299B2 (en) 2008-12-29 2021-11-16 Dispersebio Ltd. Peptides and compositions for prevention of cell adhesion and methods of using same
EP2714719B1 (en) * 2011-05-31 2018-12-12 Hutchison Biofilm Medical Solutions Limited Dispersion and detachment of cell aggregates
US9423402B2 (en) 2011-11-30 2016-08-23 Singapore Health Services Pte. Ltd. GM1 ganglioside to annexin V microparticle polypeptide ratio for biological monitoring
ES2757563T3 (es) * 2013-10-31 2020-04-29 Hutchison Biofilm Medical Solutions Ltd Uso de péptidos en resistencia a antibióticos
JP6443235B2 (ja) * 2015-06-15 2018-12-26 三菱ケミカル株式会社 細胞外多糖類の検出を使用した汚泥の脱水方法
KR101819190B1 (ko) * 2015-10-14 2018-01-16 주식회사 큐얼스 미세조류 파괴용 조성물
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
PH12021550946A1 (en) * 2018-11-01 2022-03-28 Biofouling Tech Inc Durable biofouling protection
EP3699185A1 (en) * 2019-02-20 2020-08-26 Université de Rennes 1 Peptides for preventing biofilm formation
KR102277536B1 (ko) 2019-04-25 2021-07-15 동국대학교 산학협력단 생물오손 방지를 위한 체내 삽입형 의료기기 및 체내 삽입형 의료기기의 표면에 생물오손 방지막의 형성방법
ES2947713T3 (es) 2019-06-13 2023-08-17 Hollister Inc Productos de catéter urinario reutilizables
WO2020263859A1 (en) 2019-06-25 2020-12-30 Hollister Incorporated Reusable urinary catheter products
KR102520633B1 (ko) 2021-02-17 2023-04-11 동의대학교 산학협력단 흡수성이 향상된 치과용 멤브레인 필터 및 그 제조방법
GB202305524D0 (en) * 2023-04-14 2023-05-31 Oxford Nanopore Tech Plc Novel pore monomers and pores
EP4464714A1 (en) * 2023-05-19 2024-11-20 Karlsruher Institut für Technologie Screening method for cell-repelling peptides

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154600B (nl) 1971-02-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
NL154599B (nl) 1970-12-28 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking.
US3901654A (en) 1971-06-21 1975-08-26 Biological Developments Receptor assays of biologically active compounds employing biologically specific receptors
US3853987A (en) 1971-09-01 1974-12-10 W Dreyer Immunological reagent and radioimmuno assay
US3867517A (en) 1971-12-21 1975-02-18 Abbott Lab Direct radioimmunoassay for antigens and their antibodies
NL171930C (nl) 1972-05-11 1983-06-01 Akzo Nv Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen.
US3850578A (en) 1973-03-12 1974-11-26 H Mcconnell Process for assaying for biologically active molecules
US3935074A (en) 1973-12-17 1976-01-27 Syva Company Antibody steric hindrance immunoassay with two antibodies
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4034074A (en) 1974-09-19 1977-07-05 The Board Of Trustees Of Leland Stanford Junior University Universal reagent 2-site immunoradiometric assay using labelled anti (IgG)
US3984533A (en) 1975-11-13 1976-10-05 General Electric Company Electrophoretic method of detecting antigen-antibody reaction
US4098876A (en) 1976-10-26 1978-07-04 Corning Glass Works Reverse sandwich immunoassay
US4286988A (en) 1980-06-30 1981-09-01 The United States Of America As Represented By The Secretary Of The Navy Copper base antifouling paints with pH control
US4879219A (en) 1980-09-19 1989-11-07 General Hospital Corporation Immunoassay utilizing monoclonal high affinity IgM antibodies
US4678512A (en) 1982-02-12 1987-07-07 Grams Ralph R Marine coating compositions and method
US5011771A (en) 1984-04-12 1991-04-30 The General Hospital Corporation Multiepitopic immunometric assay
US4666828A (en) 1984-08-15 1987-05-19 The General Hospital Corporation Test for Huntington's disease
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4801531A (en) 1985-04-17 1989-01-31 Biotechnology Research Partners, Ltd. Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
GB8511144D0 (en) 1985-05-02 1985-06-12 Int Paint Plc Marine anti-fouling paint
JPH07764Y2 (ja) 1987-05-19 1995-01-11 日産自動車株式会社 自動変速機のロツクアツプ制御装置
US4865909A (en) 1987-10-21 1989-09-12 W. L. Gore & Associates, Inc. Microporous anti-fouling marine coating
US5272057A (en) 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
US5192659A (en) 1989-08-25 1993-03-09 Genetype Ag Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
US5143545A (en) 1991-09-20 1992-09-01 The United States Of America As Represented By The Secretary Of The Navy Antifouling marine coatings
US5281521A (en) 1992-07-20 1994-01-25 The Trustees Of The University Of Pennsylvania Modified avidin-biotin technique
CA2178500C (en) 1993-12-09 2004-07-13 Gordon T. Taylor Aquatic antifouling compositions and methods
AUPQ002399A0 (en) * 1999-04-28 1999-05-20 Australian National University, The Model membrane systems
US7834146B2 (en) 2000-05-08 2010-11-16 Monsanto Technology Llc Recombinant polypeptides associated with plants
US7556807B2 (en) 2001-02-20 2009-07-07 Kane Biotech, Inc. Signal peptides, nucleic acid molecules and methods for treatment of caries
US7189351B2 (en) * 2001-10-25 2007-03-13 Spherix Incorporated D-tagatose as an anti-biofilm agent
AU2002363966A1 (en) 2001-12-07 2003-06-23 Vitesse Semiconductor Company A method and system for transporting information via the xgmii or fiber channel standard
GB0200689D0 (en) * 2002-01-10 2002-02-27 Univ Newcastle Fusion proteins
CN1162541C (zh) * 2002-09-03 2004-08-18 中山大学 一种海葵细胞毒素基因、其编码的蛋白及应用
EP2256198A1 (en) * 2004-06-14 2010-12-01 Galapagos N.V. Methods for identification, and compounds useful for the treatment of degenerative and inflammatory diseases
ATE462451T1 (de) 2004-06-16 2010-04-15 Affinergy Inc Grenzflächenbiomaterialien zur förderung der anhaftung von zielanalyten
WO2006006172A2 (en) 2004-07-15 2006-01-19 Ramot At Tel Aviv University Ltd. Use of anti-amyloid agents for treating and typing pathogen infections
GB0502046D0 (en) * 2005-02-01 2005-03-09 Sinclair Pharmaceuticals Ltd Method
EP1919494A4 (en) * 2005-07-22 2011-11-09 Univ Colorado Regents NON-TOXIC BIOFUEL HEMMER
US8048443B2 (en) * 2005-12-16 2011-11-01 Cerapedics, Inc. Pliable medical device and method of use
WO2007147098A2 (en) 2006-06-16 2007-12-21 Tufts University Identification and use of non-peptide analogs of rnaiii-inhibiting peptide for the treatment of staphylococcal infections
JP2010521188A (ja) * 2007-03-22 2010-06-24 ディーエスエム アイピー アセッツ ビー.ブイ. 新規リシルオキシダーゼ
US20080241281A1 (en) 2007-03-29 2008-10-02 Texas Tech University System Compositions & methods for activation and inhibition of Staphylococcus aureus biofilm development
CN101835668A (zh) * 2007-09-20 2010-09-15 特尔哈肖梅尔医学研究基础设施和服务有限公司 用于防止细胞粘附的水生生物源组合物和其使用方法
US8551555B2 (en) * 2007-12-26 2013-10-08 Intel Corporation Biocompatible coatings for medical devices
KR101594202B1 (ko) 2008-09-24 2016-02-15 텔 하쇼머 메디컬 리서치 인프라스트럭쳐 앤드 서비시스 리미티드. 세포 유착 방지를 위한 펩티드와 조성물 및 그것의 사용 방법
EP2376528B1 (en) 2008-12-29 2014-11-26 Tel Hashomer Medical Research, Infrastructure And Services Ltd. Peptides and compositions for prevention of cell adhesion and methods of using same
EP3168504B1 (en) 2014-07-09 2020-02-19 Nissan Motor Co., Ltd. Lock-up-clutch control device

Similar Documents

Publication Publication Date Title
JP2015037545A5 (https=)
JP2016533322A5 (https=)
JP2018520654A5 (https=)
JP2018532705A5 (https=)
JP2013539361A5 (https=)
RU2015119517A (ru) Новый способ лечения инфаркта миокарда с применением фрагмента hmgb1
ES2721309T3 (es) Composición para preparar tagatosa y método para preparar tagatosa a partir de fructosa
JP2013177388A5 (https=)
WO2016193351A3 (en) Recombinant microorganism for improved production of fine chemicals
JP2015505473A5 (ja) 細胞培養のための合成接着培地
JP2016539641A5 (https=)
Pinto et al. Utilization of antimicrobial peptides, analogues and mimics in creating antimicrobial surfaces and bio-materials
WO2015185758A3 (en) Preparation comprising factor viii and von willebrand factor peptides
EP4095152A3 (en) Engineered ribosomal promoters for protein production in microorganisms
WO2017176807A3 (en) Compositions for inhibiting formation of and/or disrupting bacterial biofilms and methods of use therefor
RU2016147962A (ru) Микроорганизм, обладающий улучшенной способностью к продуцированию l-лизина, и способ производства l-лизина с использованием данного микроорганизма
US20180002535A1 (en) A method for treating a surface and an article comprising a layer of microbial structures
JP2013531491A5 (https=)
HRP20201945T1 (hr) Postupak proizvodnje gonadotropina
RU2017142878A (ru) Микроорганизм рода Escherichia, обладающий продуктивностью по L-триптофану, и способ получения L-триптофана с его использованием
JP2013504519A5 (https=)
CA3010564A1 (en) An antibacterial composition and a method of treating staphylococcal infections with the antibacterial composition
CN103931614A (zh) 一种植物病原细菌杀/抑菌剂及其应用
RU2017141773A (ru) Микроорганизм рода Escherichia, продуцирующий L-триптофан, и способ получения L-триптофана с его использованием
RU2016145258A (ru) Микроорганизм, обладающий улучшенным уровнем внутриклеточной энергии, и способ продуцирования l-аминокислоты с его помощью